Covered recipient · General Payments record
DIANE G FOUTS
Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner Family
General Payments · PY2021–2024
$1,201.11
- Reported across 33 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $435.73 | 18 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Braeburn Inc. | $151.94 | 3 |
| Lundbeck LLC | $93.43 | 5 |
| Indivior Inc. | $45.33 | 2 |
| Axsome Therapeutics, Inc. | $37.74 | 2 |
| Alkermes, Inc. | $36.96 | 2 |
| Teva Pharmaceuticals USA, Inc. | $30.60 | 2 |
| VERTEX PHARMACEUTICALS INCORPORATED | $20.47 | 1 |
| Otsuka America Pharmaceutical, Inc. | $19.26 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (18)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Alkermes, Inc. | $17.67 | 05/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1120500274 | CMS |
| Alkermes, Inc. | $19.29 | 08/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1120500276 | CMS |
| Axsome Therapeutics, Inc. | $16.53 | 05/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1148354660 | CMS |
| Axsome Therapeutics, Inc. | $21.21 | 06/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1148354658 | CMS |
| Braeburn Inc. | $21.98 | 05/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1125612705 | CMS |
| Braeburn Inc. | $125.00 | 07/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1125612709 | CMS |
| Braeburn Inc. | $4.96 | 10/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1125612707 | CMS |
| Indivior Inc. | $22.25 | 04/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1144552474 | CMS |
| Indivior Inc. | $23.08 | 10/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1144552476 | CMS |
| Lundbeck LLC | $15.80 | 02/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1146022129 | CMS |
| Lundbeck LLC | $14.93 | 04/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1146022131 | CMS |
| Lundbeck LLC | $20.28 | 06/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1146022133 | CMS |
| Lundbeck LLC | $21.42 | 07/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1146022135 | CMS |
| Lundbeck LLC | $21.00 | 10/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1146022137 | CMS |
| Otsuka America Pharmaceutical, Inc. | $19.26 | 12/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1119073211 | CMS |
| Teva Pharmaceuticals USA, Inc. | $16.26 | 03/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151486363 | CMS |
| Teva Pharmaceuticals USA, Inc. | $14.34 | 09/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151486445 | CMS |
| VERTEX PHARMACEUTICALS INCORPORATED | $20.47 | 11/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105906747 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.